Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Growth and maturity status of black and white children classified as obese by different criteria.

American journal of human biology : the official journal of the Human Biology Council

Malina RM, Skrabanek MF, Little BB.
PMID: 28514012
Am J Hum Biol. 1989;1(2):193-199. doi: 10.1002/ajhb.1310010208.

Weight, stature, bicondylar and biepicondylar breadths, estimated midarm muscle circumference, grip strength, and skeletal maturity were compared in 111 obese Black and 120 obese White children, 6 through 12 years of age. The children were classified as obese by...

Cite
Malina RM, Skrabanek MF, Little BB. Growth and maturity status of black and white children classified as obese by different criteria. Am J Hum Biol. 1989;1(2):193-199doi: 10.1002/ajhb.1310010208.
Malina, R. M., Skrabanek, M. F., & Little, B. B. (1989). Growth and maturity status of black and white children classified as obese by different criteria. American journal of human biology : the official journal of the Human Biology Council, 1(2), 193-199. https://doi.org/10.1002/ajhb.1310010208
Malina, Robert M, et al. "Growth and maturity status of black and white children classified as obese by different criteria." American journal of human biology : the official journal of the Human Biology Council vol. 1,2 (1989): 193-199. doi: https://doi.org/10.1002/ajhb.1310010208
Malina RM, Skrabanek MF, Little BB. Growth and maturity status of black and white children classified as obese by different criteria. Am J Hum Biol. 1989;1(2):193-199. doi: 10.1002/ajhb.1310010208. PMID: 28514012.
Copy Download .nbib Format: NLM
Health quackery - holding back the tide.

The International journal of risk & safety in medicine

Skrabanek P.
PMID: 23511509
Int J Risk Saf Med. 1990;1(1):65-9. doi: 10.3233/JRS-1990-1111.

No abstract available.

Cite
Skrabanek P. Health quackery - holding back the tide. Int J Risk Saf Med. 1990;1(1):65-9doi: 10.3233/JRS-1990-1111.
Skrabanek, P. (1990). Health quackery - holding back the tide. The International journal of risk & safety in medicine, 1(1), 65-9. https://doi.org/10.3233/JRS-1990-1111
Skrabanek, P. "Health quackery - holding back the tide." The International journal of risk & safety in medicine vol. 1,1 (1990): 65-9. doi: https://doi.org/10.3233/JRS-1990-1111
Skrabanek P. Health quackery - holding back the tide. Int J Risk Saf Med. 1990;1(1):65-9. doi: 10.3233/JRS-1990-1111. PMID: 23511509.
Copy Download .nbib Format: NLM
Tumour devascularisation as a potential immunotherapeutic strategy.

Oncoimmunology

Buchler T, Vasek P, Spisek R, Skrobanek P, Horejsi V.
PMID: 30546967
Oncoimmunology. 2018 Oct 11;8(1):e1526614. doi: 10.1080/2162402X.2018.1526614. eCollection 2019.

Complete tumour devascularisation (CTD) is a surgical technique which entails the complete disruption by ligation or cutting of afferent and efferent tumour vasculature which remains in situ. In some animal models, CTD induces immune responses that lead to regression...

Cite
Buchler T, Vasek P, Spisek R, et al. Tumour devascularisation as a potential immunotherapeutic strategy. Oncoimmunology. 2018;8(1):e1526614doi: 10.1080/2162402X.2018.1526614.
Buchler, T., Vasek, P., Spisek, R., Skrobanek, P., & Horejsi, V. (2019). Tumour devascularisation as a potential immunotherapeutic strategy. Oncoimmunology, 8(1), e1526614. https://doi.org/10.1080/2162402X.2018.1526614
Buchler, Tomas, et al. "Tumour devascularisation as a potential immunotherapeutic strategy." Oncoimmunology vol. 8,1 (2019): e1526614. doi: https://doi.org/10.1080/2162402X.2018.1526614
Buchler T, Vasek P, Spisek R, Skrobanek P, Horejsi V. Tumour devascularisation as a potential immunotherapeutic strategy. Oncoimmunology. 2018 Oct 11;8(1):e1526614. doi: 10.1080/2162402X.2018.1526614. eCollection 2019. PMID: 30546967; PMCID: PMC6287775.
Copy Download .nbib Format: NLM
Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin.

The Journal of molecular diagnostics : JMD

Nguyen H, Perry A, Skrabek P, Nasr M, Herrera AF, Bedell V, Murata-Collins J, Pillai R, Xu M, Chen L, Chan WC, Weisenburger DD, Scott DW, Song JY.
PMID: 33636392
J Mol Diagn. 2021 May;23(5):658-664. doi: 10.1016/j.jmoldx.2021.02.005. Epub 2021 Feb 23.

The prognosis of diffuse large B-cell lymphoma (DLBCL) has been associated with clinical parameters, cell of origin, and various genetic aberrations. Recently, a NanoString gene expression assay (DLBCL90) was developed, which identifies DLBCL cases with an outcome similar to...

Cite
Nguyen H, Perry A, Skrabek P, et al. Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin. J Mol Diagn. 2021;23(5):658-664doi: 10.1016/j.jmoldx.2021.02.005.
Nguyen, H., Perry, A., Skrabek, P., Nasr, M., Herrera, A. F., Bedell, V., Murata-Collins, J., Pillai, R., Xu, M., Chen, L., Chan, W. C., Weisenburger, D. D., Scott, D. W., & Song, J. Y. (2021). Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin. The Journal of molecular diagnostics : JMD, 23(5), 658-664. https://doi.org/10.1016/j.jmoldx.2021.02.005
Nguyen, Ha, et al. "Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin." The Journal of molecular diagnostics : JMD vol. 23,5 (2021): 658-664. doi: https://doi.org/10.1016/j.jmoldx.2021.02.005
Nguyen H, Perry A, Skrabek P, Nasr M, Herrera AF, Bedell V, Murata-Collins J, Pillai R, Xu M, Chen L, Chan WC, Weisenburger DD, Scott DW, Song JY. Validation of the Double-Hit Gene Expression Signature (DLBCL90) in an Independent Cohort of Patients with Diffuse Large B-Cell Lymphoma of Germinal Center Origin. J Mol Diagn. 2021 May;23(5):658-664. doi: 10.1016/j.jmoldx.2021.02.005. Epub 2021 Feb 23. PMID: 33636392; PMCID: PMC8185969.
Copy Download .nbib Format: NLM
Circulating immunoreactive substance P in man.

Irish journal of medical science

Skrabanek P, Cannon D, Kirrane J, Legge D, Powell D.
PMID: 27517263
Ir J Med Sci. 1976 Dec;145(1):399. doi: 10.1007/BF02938979.

Immunoreactive substance P (iSP) has been measured in plasma in 77 normal subjects and in 125 hospital patients. Factors affectingin-vitro degradation of iSP were studied.In vivo, iSP is degraded in the liver and its level in the circulation is...

Cite
Skrabanek P, Cannon D, Kirrane J, et al. Circulating immunoreactive substance P in man. Ir J Med Sci. 1976;145(1):399doi: 10.1007/BF02938979.
Skrabanek, P., Cannon, D., Kirrane, J., Legge, D., & Powell, D. (1976). Circulating immunoreactive substance P in man. Irish journal of medical science, 145(1), 399. https://doi.org/10.1007/BF02938979
Skrabanek, P, et al. "Circulating immunoreactive substance P in man." Irish journal of medical science vol. 145,1 (1976): 399. doi: https://doi.org/10.1007/BF02938979
Skrabanek P, Cannon D, Kirrane J, Legge D, Powell D. Circulating immunoreactive substance P in man. Ir J Med Sci. 1976 Dec;145(1):399. doi: 10.1007/BF02938979. PMID: 27517263.
Copy Download .nbib Format: NLM
Double-hit Signature with .

Clinical cancer research : an official journal of the American Association for Cancer Research

Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD.
PMID: 33414134
Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 07.

PURPOSE: We performed detailed genomic analysis on 87 cases of EXPERIMENTAL DESIGN: The cases were extensively characterized by combining the results of IHC, cell-of-origin gene expression profiling (GEP; NanoString), double-hit GEP (DLBCL90), FISH cytogenetic analysis for double/triple-hit lymphoma, copy-number...

Cite
Song JY, Perry AM, Herrera AF, et al. Double-hit Signature with . Clin Cancer Res. 2021;27(6):1671-1680doi: 10.1158/1078-0432.CCR-20-2378.
Song, J. Y., Perry, A. M., Herrera, A. F., Chen, L., Skrabek, P., Nasr, M. R., Ottesen, R. A., Nikowitz, J., Bedell, V., Murata-Collins, J., Li, Y., McCarthy, C., Pillai, R., Wang, J., Wu, X., Zain, J., Popplewell, L., Kwak, L. W., Nademanee, A. P., Niland, J. C., Scott, D. W., Gong, Q., Chan, W. C., & Weisenburger, D. D. (2021). Double-hit Signature with . Clinical cancer research : an official journal of the American Association for Cancer Research, 27(6), 1671-1680. https://doi.org/10.1158/1078-0432.CCR-20-2378
Song, Joo Y, et al. "Double-hit Signature with ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,6 (2021): 1671-1680. doi: https://doi.org/10.1158/1078-0432.CCR-20-2378
Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD. Double-hit Signature with . Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 07. PMID: 33414134.
Copy Download .nbib Format: NLM
Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients.

Frontiers in oncology

Cervena K, Novosadova V, Pardini B, Naccarati A, Opattova A, Horak J, Vodenkova S, Buchler T, Skrobanek P, Levy M, Vodicka P, Vymetalkova V.
PMID: 34540669
Front Oncol. 2021 Sep 02;11:702258. doi: 10.3389/fonc.2021.702258. eCollection 2021.

MicroRNAs (miRNAs) regulate gene expression in a tissue-specific manner. However, little is known about the miRNA expression changes induced by the therapy in rectal cancer (RC) patients. We evaluated miRNA expression levels before and after therapy and identified specific...

Cite
Cervena K, Novosadova V, Pardini B, et al. Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients. Front Oncol. 2021;11:702258doi: 10.3389/fonc.2021.702258.
Cervena, K., Novosadova, V., Pardini, B., Naccarati, A., Opattova, A., Horak, J., Vodenkova, S., Buchler, T., Skrobanek, P., Levy, M., Vodicka, P., & Vymetalkova, V. (2021). Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients. Frontiers in oncology, 11702258. https://doi.org/10.3389/fonc.2021.702258
Cervena, Klara, et al. "Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients." Frontiers in oncology vol. 11 (2021): 702258. doi: https://doi.org/10.3389/fonc.2021.702258
Cervena K, Novosadova V, Pardini B, Naccarati A, Opattova A, Horak J, Vodenkova S, Buchler T, Skrobanek P, Levy M, Vodicka P, Vymetalkova V. Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients. Front Oncol. 2021 Sep 02;11:702258. doi: 10.3389/fonc.2021.702258. eCollection 2021. PMID: 34540669; PMCID: PMC8444897.
Copy Download .nbib Format: NLM
Coronary heart disease prevention.

Lancet (London, England)

McCormick JS, Skrabanek P.
PMID: 2903393
Lancet. 1988 Nov 19;2(8621):1189-90. doi: 10.1016/s0140-6736(88)90252-8.

No abstract available.

Cite
McCormick JS, Skrabanek P. Coronary heart disease prevention. Lancet. 1988;2(8621):1189-90doi: 10.1016/s0140-6736(88)90252-8.
McCormick, J. S., & Skrabanek, P. (1988). Coronary heart disease prevention. Lancet (London, England), 2(8621), 1189-90. https://doi.org/10.1016/s0140-6736(88)90252-8
McCormick, J S, and Skrabanek, P. "Coronary heart disease prevention." Lancet (London, England) vol. 2,8621 (1988): 1189-90. doi: https://doi.org/10.1016/s0140-6736(88)90252-8
McCormick JS, Skrabanek P. Coronary heart disease prevention. Lancet. 1988 Nov 19;2(8621):1189-90. doi: 10.1016/s0140-6736(88)90252-8. PMID: 2903393.
Copy Download .nbib Format: NLM
Dynamic response of ultrathin highly dense ZIF-8 nanofilms.

Chemical communications (Cambridge, England)

Cookney J, Ogieglo W, Hrabanek P, Vankelecom I, Fila V, Benes NE.
PMID: 25142780
Chem Commun (Camb). 2014 Oct 11;50(79):11698-700. doi: 10.1039/c4cc04754k.

Ultrathin ZIF-8 nanofilms are prepared by facile step-by-step dip coating. A critical withdrawal speed allows for films with a very uniform minimum thickness. The high refractive index of the films denotes the absence of mesopores. The dynamic response of...

Cite
Cookney J, Ogieglo W, Hrabanek P, et al. Dynamic response of ultrathin highly dense ZIF-8 nanofilms. Chem Commun (Camb). 2014;50(79):11698-700doi: 10.1039/c4cc04754k.
Cookney, J., Ogieglo, W., Hrabanek, P., Vankelecom, I., Fila, V., & Benes, N. E. (2014). Dynamic response of ultrathin highly dense ZIF-8 nanofilms. Chemical communications (Cambridge, England), 50(79), 11698-700. https://doi.org/10.1039/c4cc04754k
Cookney, Joanna, et al. "Dynamic response of ultrathin highly dense ZIF-8 nanofilms." Chemical communications (Cambridge, England) vol. 50,79 (2014): 11698-700. doi: https://doi.org/10.1039/c4cc04754k
Cookney J, Ogieglo W, Hrabanek P, Vankelecom I, Fila V, Benes NE. Dynamic response of ultrathin highly dense ZIF-8 nanofilms. Chem Commun (Camb). 2014 Oct 11;50(79):11698-700. doi: 10.1039/c4cc04754k. PMID: 25142780.
Copy Download .nbib Format: NLM
High-sensitivity radioimmunoassay for substance P.

Irish journal of medical science

O'Connell R, Skrabanek P, Cannon D, Powell D.
PMID: 27517262
Ir J Med Sci. 1976 Dec;145(1):392. doi: 10.1007/BF02938978.

Optimisation of a non-equilibrium radioimmunoassay for substance P is described. The assay has a sensitivity of 2 pg (1.5 fmole), sufficient for substance P determinations in unexcepted human plasma and other biological material. The specificity of antisera used was...

Cite
O'Connell R, Skrabanek P, Cannon D, et al. High-sensitivity radioimmunoassay for substance P. Ir J Med Sci. 1976;145(1):392doi: 10.1007/BF02938978.
O'Connell, R., Skrabanek, P., Cannon, D., & Powell, D. (1976). High-sensitivity radioimmunoassay for substance P. Irish journal of medical science, 145(1), 392. https://doi.org/10.1007/BF02938978
O'Connell, R, et al. "High-sensitivity radioimmunoassay for substance P." Irish journal of medical science vol. 145,1 (1976): 392. doi: https://doi.org/10.1007/BF02938978
O'Connell R, Skrabanek P, Cannon D, Powell D. High-sensitivity radioimmunoassay for substance P. Ir J Med Sci. 1976 Dec;145(1):392. doi: 10.1007/BF02938978. PMID: 27517262.
Copy Download .nbib Format: NLM
In defense of destructive criticism. (A dialogue between a critic C and an apologist A in an unnamed medical school).

Perspectives in biology and medicine

Skrabanek P.
PMID: 3797210
Perspect Biol Med. 1986;30(1):19-26. doi: 10.1353/pbm.1986.0090.

No abstract available.

Cite
Skrabanek P. In defense of destructive criticism. (A dialogue between a critic C and an apologist A in an unnamed medical school). Perspect Biol Med. 1986;30(1):19-26doi: 10.1353/pbm.1986.0090.
Skrabanek, P. (1986). In defense of destructive criticism. (A dialogue between a critic C and an apologist A in an unnamed medical school). Perspectives in biology and medicine, 30(1), 19-26. https://doi.org/10.1353/pbm.1986.0090
Skrabanek, P. "In defense of destructive criticism. (A dialogue between a critic C and an apologist A in an unnamed medical school)." Perspectives in biology and medicine vol. 30,1 (1986): 19-26. doi: https://doi.org/10.1353/pbm.1986.0090
Skrabanek P. In defense of destructive criticism. (A dialogue between a critic C and an apologist A in an unnamed medical school). Perspect Biol Med. 1986;30(1):19-26. doi: 10.1353/pbm.1986.0090. PMID: 3797210.
Copy Download .nbib Format: NLM
Positive pregnancy tests and gynaecomastia in extragonadal germ-cell tumours.

Irish journal of medical science

Skrabanek P, Powell D, Connolly CE.
PMID: 27517401
Ir J Med Sci. 1979 Dec;148(1):118. doi: 10.1007/BF02938063.

No abstract available.

Cite
Skrabanek P, Powell D, Connolly CE. Positive pregnancy tests and gynaecomastia in extragonadal germ-cell tumours. Ir J Med Sci. 1979;148(1):118doi: 10.1007/BF02938063.
Skrabanek, P., Powell, D., & Connolly, C. E. (1979). Positive pregnancy tests and gynaecomastia in extragonadal germ-cell tumours. Irish journal of medical science, 148(1), 118. https://doi.org/10.1007/BF02938063
Skrabanek, P, et al. "Positive pregnancy tests and gynaecomastia in extragonadal germ-cell tumours." Irish journal of medical science vol. 148,1 (1979): 118. doi: https://doi.org/10.1007/BF02938063
Skrabanek P, Powell D, Connolly CE. Positive pregnancy tests and gynaecomastia in extragonadal germ-cell tumours. Ir J Med Sci. 1979 Dec;148(1):118. doi: 10.1007/BF02938063. PMID: 27517401.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries